Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis

Related Experiment Video

Updated: Sep 29, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

H Kuhn1, U Liebers, C Gessner

  • 1Dept of Pneumology, Medical Clinic I, University Leipzig, Germany. kuhnh@medizin.uni-leipzig.de

The European Respiratory Journal
|October 3, 2002
PubMed

Insights

Adenovirus-mediated transfer of E2F-1 effectively inhibits non-small cell lung cancer (NSCLC) growth by inducing apoptosis. This gene therapy approach shows promise for treating NSCLC, regardless of tumor genomic status.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Overexpression of E2F-1 is known to induce apoptosis.
  • Non-small cell lung cancer (NSCLC) remains a significant health concern with limited treatment options.

Purpose of the Study:

  • To investigate the efficacy of adenovirus-mediated transfer of E2F-1 in inhibiting tumor growth in NSCLC cell lines.
  • To assess the impact of E2F-1 on cancer cell proliferation, viability, and apoptosis.

Main Methods:

  • Adenovirus-mediated E2F-1 gene transfer (AdE2F) into three NSCLC cell lines.
  • Assessment of cell proliferation and viability using trypan blue exclusion.
  • Evaluation of apoptosis induction via flow cytometry and poly-adenosine diphosphate-ribose-polymerase (PARP) cleavage assay.
  • In vivo studies using severe combined immunodeficiency (SCID) mice with implanted tumors.

Main Results:

  • Overexpression of E2F-1 significantly suppressed tumor cell growth in vitro.
  • AdE2F treatment led to a dramatic increase in apoptotic cells 96 hours post-infection.
  • Inhibition of cell growth and apoptosis induction were independent of the cell lines' genomic status.
  • AdE2F administration inhibited tumor growth in SCID mice.

Conclusions:

  • Adenovirus-mediated E2F-1 gene therapy demonstrates potential for treating non-small cell lung cancer.
  • E2F-1 acts as a potent inducer of apoptosis in NSCLC cells.
  • The therapeutic effect of E2F-1 is not contingent on the specific genomic alterations within the cancer cells.

More Related Videos

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...